文献速递胃肠外科围术期管理与 ERAS

胃旁路术后食管腺癌风险下降:北欧三国队列研究

Decreased Risk of Esophageal Adenocarcinoma After Gastric Bypass Surgery in a Cohort Study From 3 Nordic Countries.
PubMed 文献 · Ann Surg · 2023-07-14

该研究基于瑞典、芬兰和丹麦的肥胖诊断人群队列,比较胃旁路手术组与非手术组食管及贲门腺癌(ECA)的发生风险。结果显示胃旁路术后食管腺癌风险显著降低(校正HR=0.3,95%CI 0.1-0.8),而贲门腺癌风险无显著变化(HR=0.9,95%CI 0.5-1.6)。

要点

  • 胃旁路术后食管腺癌风险显著下降,贲门腺癌风险未见下降。
  • 胃旁路组整体ECA风险较非手术肥胖组降低(校正HR=0.6,95%CI 0.4-1.0)。
  • 其他减重术式与ECA未见一致关联。

核心结论

  • 胃旁路手术可能抑制重度肥胖个体食管腺癌的发生。

研究设计与样本

  • 基于瑞典、芬兰、丹麦三国肥胖诊断患者的人群队列研究,共纳入748,932例,其中91,731例接受减重手术,以胃旁路为主(n=70,176,76.5%)。
  • 先以标准化发病比(SIR,95%CI)与背景人群比较,再用多因素Cox回归比较手术组与非手术组,校正性别、年龄、合并症、日历年和国家。

主要发现

  • 胃旁路术后ECA的SIR随时间下降,术后2至5年为2.2(95%CI 0.9-4.3),术后10至40年为0.6(95%CI <0.1-3.6)。
  • 胃旁路组较非手术肥胖组ECA风险降低,校正HR=0.6(95%CI 0.4-1.0,0.98),点估计随时间下降。
  • 单独分析显示胃旁路术后食管腺癌校正风险显著降低(HR=0.3,95%CI 0.1-0.8),贲门腺癌无显著变化(HR=0.9,95%CI 0.5-1.6)。
  • 其他减重术式(主要为胃成形术、胃束带术、袖状胃切除术和胆胰转流术)与ECA未见一致关联。

临床怎么用

  • 对重度肥胖患者,胃旁路手术除减重外可能降低食管腺癌风险,可作为术式选择时的参考信息。
  • 术后随访中仍需关注贲门腺癌风险,因其未见下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to test the hypothesis that bariatric surgery decreases the risk of esophageal and cardia adenocarcinoma. BACKGROUND: Obesity is strongly associated with esophageal adenocarcinoma and moderately with cardia adenocarcinoma, but whether weight loss prevents these tumors is unknown. METHODS: This population-based cohort study included patients with an obesity diagnosis in Sweden, Finland, or Denmark. Participants were divided into a bariatric surgery group and a nonoperated group. The incidence of esophageal and cardia adenocarcinoma (ECA) was first compared with the corresponding background population by calculating standardized incidence ratios (SIR) with 95% CIs. Second, the bariatric surgery group and the nonoperated group were compared using multivariable Cox regression, providing hazard ratios (HR) with 95% CI, adjusted for sex, age, comorbidity, calendar year, and country. RESULTS: Among 748,932 participants with an obesity diagnosis, 91,731 underwent bariatric surgery, predominantly gastric bypass (n=70,176; 76.5%). The SIRs of ECA decreased over time after gastric bypass, from SIR=2.2 (95% CI, 0.9-4.3) after 2 to 5 years to SIR=0.6 (95% CI, <0.1-3.6) after 10 to 40 years. Gastric bypass patients were also at a decreased risk of ECA compared with nonoperated patients with obesity [adjusted HR=0.6, 95% CI, 0.4-1.0 (0.98)], with decreasing point estimates over time. Gastric bypass was followed by a strongly decreased adjusted risk of esophageal adenocarcinoma (HR=0.3, 95% CI, 0.1-0.8) but not of cardia adenocarcinoma (HR=0.9, 95% CI, 0.5-1.6), when analyzed separately. There were no consistent associations between other bariatric procedures (mainly gastroplasty, gastric banding, sleeve gastrectomy, and biliopancreatic diversion) and ECA. CONCLUSIONS: Gastric bypass surgery may counteract the development of esophageal adenocarcinoma in morbidly obese individuals.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Hardvik Åkerström J, Santoni G, von Euler Chelpin M, et al. Decreased Risk of Esophageal Adenocarcinoma After Gastric Bypass Surgery in a Cohort Study From 3 Nordic Countries. Ann Surg. 2023. PMID: 37450697. doi:10.1097/SLA.0000000000006003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。